LTRN
Lantern Pharma Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$3.230
Haut
$3.230
Bas
$3.230
Volume
0.11M
Fondamentaux de l'Entreprise
Statistiques de Trading
Actualités Connexes
Lantern Pharma Reports First Quarter 2025 Financial Results and Business Updates
Completion of LP-184 Phase 1a clinical trial enrollment with 62-65 patients across a range of solid tumors expected by end of June 2025. Additional patient data readout from the HARMONIC™ Trial evaluating
Lantern Advances Drug Candidate LP-184 with IND Clearance for Phase 1b/2 Clinical Trial in Triple Negative Breast Cancer (TNBC)
The FDA has cleared the investigational new drug (IND) application of LP-184 in triple negative breast cancer (TNBC) treatment – a novel small molecule advanced and developed with Lantern's AI platform,
Actions Connexes
SUI
Sun Communities Inc.
AACG
ATA Creativity Global American Depositary Shares
KHC
The Kraft Heinz Company
CEROW
CERo Therapeutics Holdings Inc. Warrants
JAZZ
Jazz Pharmaceuticals plc (Ireland)
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.